Global Novel Drug Delivery Systems for Cancer Therapy Market by Technologies, Trends and Forecast to 2021, New Report by iHealthcareAnalyst, Inc.
Novel Drug Delivery Systems for Cancer Therapy Market by Technology Types - Embolization Particles, Drug Eluting Beads, PVA Particles, Microspheres, Gelatin-Based, Selective Internal Radiation Therapy (SIRT), Therasphere, SIR-Spheres, Holmium-Based Microspheres, Liquid Embolics, Onyx (LES and HD-500), TRUFILL nBCA LES, and Nanoparticles and Forecast 2017-2021
Maryland Heights, MO, May 09, 2017 --(PR.com)-- Novel drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. The novel drug delivery systems minimize drug degradation and loss, prevent harmful side-effects and increase drug bioavailability and the fraction of the drug accumulated in the required zone. A large variety of embolic agents are used by interventional radiologists for the selective occlusion of arteries supplying blood to tumors which depends on various factors including size of the vessel to be embolized, duration of the vessel to be occluded, desired clinical outcome and also the intrinsic properties and behavior of the agent.
Browse Novel Drug Delivery Systems for Cancer Therapy Market by Technology Types - Embolization Particles, Drug Eluting Beads, PVA Particles, Microspheres, Gelatin-Based, Selective Internal Radiation Therapy (SIRT), Therasphere, SIR-Spheres, Holmium-Based Microspheres, Liquid Embolics, Onyx (LES and HD-500), TRUFILL nBCA LES, and Nanoparticles and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/novel-drug-delivery-systems-cancer-therapy-market/
The global novel drug delivery systems for cancer therapy market segmentation is based on technology types such as embolization particles, drug eluting beads, PVA particles, microspheres, gelatin-based, selective internal radiation therapy (SIRT), TheraSphere, SIR-Spheres, Holmium-based Microspheres, Liquid Embolics, Onyx (LES and HD-500), TRUFILL nBCA LES, and nanoparticles.
The global novel drug delivery systems for cancer therapy market report provides market size (Revenue USD Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021). The global novel drug delivery systems for cancer therapy market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global novel drug delivery systems for cancer therapy market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global novel drug delivery systems for cancer therapy market and included in this report are Advanced Medical Isotope Corporation, Bind Therapeutics, Boston Scientific Corporation, BTG plc, CeloNova BioSciences, Inc., Cook Medical, Inc., Cospheric LLC, Covidien, plc, Eckert & Ziegler BEBIG, EmboMedics, Inc., Kobo Products, Inc., Merit Medical Systems, Inc., Mo-Sci Corporation, Nanobiotix, Polysciences, Inc., Sirtex Medical, Inc. and Terumo Medical Corporation.
1. Technology
1.1.1. Drug Eluting Beads
1.1.2. PVA particles, microspheres, gelatin-based
1.1.3. Selective Internal Radiation Therapy (SIRT)
1.1.4. TheraSphere
1.1.5. SIR-Spheres
1.1.6. Holmium-based Microspheres
1.1.7. Liquid Embolics
1.1.7.1. Onyx (LES and HD-500)
1.1.7.2. TRUFILL nBCA LES
1.1.8. Nanoparticles
2. Geography (Region, Country)
2.1. North America (U.S., Canada)
2.2. Latin America (Brazil, Mexico, Rest of LA)
2.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4. Asia Pacific (Japan, China, India, Rest of APAC)
2.5. Rest of the World
3. Company Profiles
3.1. Advanced Medical Isotope Corporation
3.2. Bind Therapeutics
3.3. Boston Scientific Corporation
3.4. BTG plc
3.5. CeloNova BioSciences, Inc.
3.6. Cook Medical, Inc.
3.7. Cospheric LLC
3.8. Covidien, plc
3.9. Eckert & Ziegler BEBIG
3.10. EmboMedics, Inc.
3.11. Kobo Products, Inc.
3.12. Merit Medical Systems, Inc.
3.13. Mo-Sci Corporation
3.14. Nanobiotix
3.15. Polysciences, Inc.
3.16. Sirtex Medical, Inc.
3.17. Terumo Medical Corporation
To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/novel-drug-delivery-systems-cancer-therapy-market/
About Us
iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.
Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
Website: https://www.ihealthcareanalyst.com
Browse Novel Drug Delivery Systems for Cancer Therapy Market by Technology Types - Embolization Particles, Drug Eluting Beads, PVA Particles, Microspheres, Gelatin-Based, Selective Internal Radiation Therapy (SIRT), Therasphere, SIR-Spheres, Holmium-Based Microspheres, Liquid Embolics, Onyx (LES and HD-500), TRUFILL nBCA LES, and Nanoparticles and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/novel-drug-delivery-systems-cancer-therapy-market/
The global novel drug delivery systems for cancer therapy market segmentation is based on technology types such as embolization particles, drug eluting beads, PVA particles, microspheres, gelatin-based, selective internal radiation therapy (SIRT), TheraSphere, SIR-Spheres, Holmium-based Microspheres, Liquid Embolics, Onyx (LES and HD-500), TRUFILL nBCA LES, and nanoparticles.
The global novel drug delivery systems for cancer therapy market report provides market size (Revenue USD Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021). The global novel drug delivery systems for cancer therapy market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global novel drug delivery systems for cancer therapy market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global novel drug delivery systems for cancer therapy market and included in this report are Advanced Medical Isotope Corporation, Bind Therapeutics, Boston Scientific Corporation, BTG plc, CeloNova BioSciences, Inc., Cook Medical, Inc., Cospheric LLC, Covidien, plc, Eckert & Ziegler BEBIG, EmboMedics, Inc., Kobo Products, Inc., Merit Medical Systems, Inc., Mo-Sci Corporation, Nanobiotix, Polysciences, Inc., Sirtex Medical, Inc. and Terumo Medical Corporation.
1. Technology
1.1.1. Drug Eluting Beads
1.1.2. PVA particles, microspheres, gelatin-based
1.1.3. Selective Internal Radiation Therapy (SIRT)
1.1.4. TheraSphere
1.1.5. SIR-Spheres
1.1.6. Holmium-based Microspheres
1.1.7. Liquid Embolics
1.1.7.1. Onyx (LES and HD-500)
1.1.7.2. TRUFILL nBCA LES
1.1.8. Nanoparticles
2. Geography (Region, Country)
2.1. North America (U.S., Canada)
2.2. Latin America (Brazil, Mexico, Rest of LA)
2.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4. Asia Pacific (Japan, China, India, Rest of APAC)
2.5. Rest of the World
3. Company Profiles
3.1. Advanced Medical Isotope Corporation
3.2. Bind Therapeutics
3.3. Boston Scientific Corporation
3.4. BTG plc
3.5. CeloNova BioSciences, Inc.
3.6. Cook Medical, Inc.
3.7. Cospheric LLC
3.8. Covidien, plc
3.9. Eckert & Ziegler BEBIG
3.10. EmboMedics, Inc.
3.11. Kobo Products, Inc.
3.12. Merit Medical Systems, Inc.
3.13. Mo-Sci Corporation
3.14. Nanobiotix
3.15. Polysciences, Inc.
3.16. Sirtex Medical, Inc.
3.17. Terumo Medical Corporation
To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/novel-drug-delivery-systems-cancer-therapy-market/
About Us
iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.
Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
Website: https://www.ihealthcareanalyst.com
Contact
iHealthcareAnalyst, Inc.
Ana Aitawa
(314) 500-7508
https://www.ihealthcareanalyst.com/
Ana Aitawa
(314) 500-7508
https://www.ihealthcareanalyst.com/
Contact
Categories